Monday, 26 August 2013

There is insufficient evidence linking diabetes drugs with increase risk of cancer and as per FDA, doctors can continue to confidently prescribe all approved drugs for the management of the diabetes, as per a joint consensus statement released by American College of Endocrinology and American Association of Clinical Endocrinologist.  The statement was released on 20th August, 2013.  Recently some reports have linked incretin drugs with pancreatic cancer and lantus insulin with cancer.  As per the statement both diabetes and obesity may increase the risk of certain cancer, therefore, it is difficult to say that the drugs are linked to it.  

No comments:

Post a Comment